RAY SALEMME holds a BA in Molecular Biophysics from Yale University, and a PhD
in Chemistry from UCSD. Following a successful academic career, he moved to work
in the biotechnology industry in 1982. He subsequently worked for several years
at DuPont Central Research, DuPont Merck Pharmaceuticals and Sterling Winthrop
Pharmaceuticals. In 1993, Dr. Salemme founded 3-Dimensional Pharmaceuticals
(3DP), an advanced drug discovery company integrating combinatorial chemistry,
structure-based drug design, high throughput screening, and cheminformatics,
within a comprehensive IT infrastructure. 3DP was acquired by Johnson & Johnson
in 2003. Dr. Salemme joined Redpoint Bio as CEO in 2004.
Redpoint Bio Corporation - Ray Salemme (rpbc)
August 10, 2009